• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016 » Page 5

Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016

July 25, 2016 By Fink Densford

Decibel taps ex-Biogen exec veep Holtzman as CEO


decibel-holtzman

Decibel Therapeutics said earlier this month it tapped former Biogen Idec (NSDQ:BIIB) corporate development exec veep Steven Holtzman as its new chief executive, taking over for interim CEO Kevin Starr.

Prior to his time with Biogen, Holtzman helped found and operated as CEO and board chair for Infinity Pharmaceuticals. Starr will stay on with the company to serve as board chair.

“Steve is a recognized leader in the development and growth of successful, product-driven biotechnology companies, and we are thrilled to welcome him to the team. Steve’s deep experience in building and leading organizations, business development, drug discovery and R&D makes him the ideal individual to cultivate our culture, team and science to pioneer the development of new therapies for the millions of people with hearing disorders,” Starr said in prepared remarks.

“Hearing loss is a profound medical, societal and human issue that affects millions of people. Through my personal experiences with close family members, I’ve witnessed the impact of hearing loss on quality of life, including how it impedes the ability to use spoken language and music as means of self-expression and communication. The early work of Decibel’s world leading founders and Third Rock Ventures, coupled with the company’s tremendous team, provides a solid foundation to develop a hearing platform to molecularly map cochlear pathology with auditory dysfunction. Throughout my career, I’ve focused on building companies that make meaningful medicines, and I look forward to partnering with and growing this team as we aim to produce a pipeline of breakthrough therapies for people with hearing loss disorders,” Holtzman said in a press release.

Read more

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Business/Financial News Tagged With: American Medical Systems Holdings Inc., AngioDynamics, Baxter, Biogen, Boston Scientific, BTG, Cardiac Sciences Corp., Decibel Therapeutics, electroCore, Galil Medical, InTouch Health, Invictus Medical, McKesson Corp., Monteris Medical, Nimbus Concepts, Smith & Nephew, Theranos, Thermo Fisher Scientific

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy